Company Announcements

INDEPENDENT REVIEW OF INVENTORY

Source: RNS
RNS Number : 2384V
Ted Baker PLC
02 December 2019
 

December 2nd 2019

Ted Baker Plc

("Ted Baker" or the "Company")

INDEPENDENT REVIEW OF INVENTORY

 

Ted Baker has identified that the value of inventory held on its balance sheet has been overstated.  Based on preliminary analysis, the Board estimates an impact on value of £20m to £25m. The Board believes that any adjustment to inventory value will have no cash impact and will relate to prior years. 

The Board has appointed Freshfields Bruckhaus Deringer LLP, and will be appointing independent accountants, to undertake a comprehensive review of this issue, and they will report to a sub-committee, chaired by independent director Sharon Baylay.  All costs and fees associated with completing the independent review will be expensed in the period incurred and clearly identified as such.

Ted Baker is committed to ensuring the independent review is completed in an efficient and transparent manner and will update the market as appropriate.   Whilst the review is ongoing, the Company will not comment further.

As scheduled, Ted Baker Plc will be announcing its Trading Update for the 17 week period from 11 August 2019 to 7 December 2019 on Wednesday 11 December 2019.

END

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) NO 596/2014.

 

Enquiries:

Ted Baker Plc

Lindsay Page, Chief Executive Officer                                                   

Rachel Osborne, Chief Financial Officer

 

Hudson Sandler LLP (public relations)                                                    Tel: +44 (0) 20 7796 4133

Alex Brennan / Hattie Dreyfus / Nick Moore

tedbaker@hudsonsandler.com


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCLLFSTFDLLIIA